Treatment of lymphangiomas by means of sclerotherapy with OK-432 (Picibanil®) is safe and effective
收藏NIAID Data Ecosystem2026-03-13 收录
官方服务：
资源简介：
Treatment of lymphangiomas by means of sclerotherapy with OK-432
应用场景：
创建时间：
2022-04-12
相关数据集
Effect of Ibrutinib on the gene expression of CD4+ cells from patients with Peripheral T-cell lymphoma (PTCL). Effect of Ibrutinib on the gene expression of CD4+ cells from patients with Peripheral T-cell lymphoma (PTCL)
Interleukin-2-inducible T-cell kinase (ITK) has essential roles in T-cell proliferation in response to T-cell receptor stimulation and promotes Th2 and Th17 cell differentiation while suppressing Treg
NIAID Data Ecosystem60
CAR T Engager Proteins Optimize Anti CD19 CAR T Cell Therapies for Lymphoma.docx
Data are graphs of binding and cytotoxicity of a novel CAR T Engager protein directed toward lymphoma. Data are derived from Aleta Biotherapeutics datasets or from CRO reports.
DataCite Commons2022-05-30 更新40
Table_1_Phase II Study of Gemcitabine, Peg-Asparaginase, Dexamethasone and Methotrexate Regimen for Newly Diagnosed Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type: Final Analysis With Long-Term Follow-Up and Rational Research for the Combination.xlsx
Patients with extranodal natural killer/T-cell lymphoma (ENKTL), nasal type are benefit from peg-asparaginase, gemcitabine, and methotrexate. Therefore, we conducted a prospective phase II trial using
NIAID Data Ecosystem20
Validation of protein arginine methyltransferase 5 (PRMT5) as a candidate therapeutic target in the spontaneous canine model of non-Hodgkin lymphoma [ATAC-seq]
Targeting PRMT5 in canine lymphoma: we characterized expression patterns of PRMT5 in canine lymphomas and correlated these with histological subtypes using tissue microarrays. We characterized express
NIAID Data Ecosystem50
North America Follicular Lymphoma Treatment Market
North America Follicular Lymphoma Treatment comes with extensive industry analysis of development components, patterns, flows, and sizes. The report calculates present and past market values to foreca
IMR REPORTS30
